Literature DB >> 12950088

Expression of NG2 proteoglycan during endochondral and intramembranous ossification.

Jun-ichi Fukushi1, Masaru Inatani, Yu Yamaguchi, William B Stallcup.   

Abstract

We have used immunohistochemistry to study the distribution of the NG2 proteoglycan during bone development in the mouse. At embryonic day 15.5, NG2 was strongly detected in the immature cartilage of developing limbs. After transient down-regulation in mature chondrocytes, NG2 was up-regulated during primary ossification, colocalizing with alkaline phosphatase and tenascin C. In the epiphyseal growth plates of newborn mouse tibia, NG2 and alkaline phosphatase exhibited overlapping patterns of expression by hypertrophic chondrocytes and by osteoblasts surrounding newly formed bone trabeculae. NG2 was down-regulated after puberty, being only faintly detectable in the tibial growth plates of 3-month-old mice. In cranial sutures, NG2 was strongly labeled in osteogenic bone fronts and in the suture matrix. Our results indicate that NG2 expression is up-regulated during both endochondral and intramembranous ossification, but is down-regulated as ossification is completed. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950088     DOI: 10.1002/dvdy.10359

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  15 in total

1.  Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines.

Authors:  Nobuo Terada; Nobuhiko Ohno; Shinichi Murata; Ryohei Katoh; William B Stallcup; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2006-04-20       Impact factor: 4.304

2.  NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse.

Authors:  Kuniko Kadoya; Jun-Ichi Fukushi; Yoshihiro Matsumoto; Yu Yamaguchi; William B Stallcup
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

3.  Differentiating zones at periodontal ligament-bone and periodontal ligament-cementum entheses.

Authors:  J-H Lee; B A Pryce; R Schweitzer; M I Ryder; S P Ho
Journal:  J Periodontal Res       Date:  2015-06-01       Impact factor: 4.419

4.  Accumulation of type VI collagen in the primary osteon of the rat femur during postnatal development.

Authors:  Yukihiro Kohara; Satoshi Soeta; Yayoi Izu; Hajime Amasaki
Journal:  J Anat       Date:  2015-05-05       Impact factor: 2.610

5.  Conditional ablation of the heparan sulfate-synthesizing enzyme Ext1 leads to dysregulation of bone morphogenic protein signaling and severe skeletal defects.

Authors:  Yoshihiro Matsumoto; Kazu Matsumoto; Fumitoshi Irie; Jun-ichi Fukushi; William B Stallcup; Yu Yamaguchi
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

Review 6.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

7.  Functional roles of CSPG4/NG2 in chondrosarcoma.

Authors:  Nuor S M Jamil; Asim Azfer; Harrison Worrell; Donald M Salter
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

8.  NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.

Authors:  Zhi-Gang She; Yunchao Chang; Hong-Bo Pang; Wenlong Han; Hou-Zao Chen; Jeffrey W Smith; William B Stallcup
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

9.  Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow.

Authors:  Bo O Zhou; Rui Yue; Malea M Murphy; James G Peyer; Sean J Morrison
Journal:  Cell Stem Cell       Date:  2014-06-19       Impact factor: 24.633

10.  Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity.

Authors:  Yunchao Chang; Zhi-Gang She; Kenji Sakimura; Amanda Roberts; Karolina Kucharova; David H Rowitch; William B Stallcup
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.